Winston Medical Supply Co., Ltd. (TPEX:6817)
Taiwan · Delayed Price · Currency is TWD 112.50
-0.50 (-0.44%)
Jul 16, 2025, 1:05 PM CST
Winston Medical Supply Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| 695.08 | 709.07 | 606.52 | 536.53 | 505.12 | Upgrade | |
Revenue Growth (YoY) | -1.97% | 16.91% | 13.05% | 6.22% | 38.43% | Upgrade |
Cost of Revenue | 379.24 | 361.48 | 342.07 | 299.13 | 301.3 | Upgrade |
Gross Profit | 315.84 | 347.6 | 264.45 | 237.39 | 203.82 | Upgrade |
Selling, General & Admin | 147.16 | 142.87 | 122.89 | 113.21 | 113.84 | Upgrade |
Research & Development | 9.43 | 8.64 | 7 | 7.72 | 6.3 | Upgrade |
Operating Expenses | 156.59 | 151.5 | 128.59 | 122.11 | 120.1 | Upgrade |
Operating Income | 159.26 | 196.1 | 135.86 | 115.29 | 83.72 | Upgrade |
Interest Expense | -1.17 | -1.53 | -1.06 | -1.84 | -3.11 | Upgrade |
Interest & Investment Income | 2.85 | 2.01 | 0.4 | 0.17 | 0.08 | Upgrade |
Currency Exchange Gain (Loss) | 0.39 | -0.19 | 0.08 | -0.2 | 0.93 | Upgrade |
Other Non Operating Income (Expenses) | 3.96 | 3.46 | 6.11 | 3.42 | 3.93 | Upgrade |
EBT Excluding Unusual Items | 165.29 | 199.85 | 141.4 | 116.84 | 85.54 | Upgrade |
Gain (Loss) on Sale of Assets | -1.11 | -1.03 | - | -0.25 | 0.21 | Upgrade |
Pretax Income | 164.18 | 198.82 | 141.4 | 116.59 | 85.75 | Upgrade |
Income Tax Expense | 32.59 | 40.06 | 30.14 | 24.46 | -13.93 | Upgrade |
Earnings From Continuing Operations | 131.59 | 158.76 | 111.26 | 92.13 | 99.69 | Upgrade |
Net Income to Company | 131.59 | 158.76 | 111.26 | 92.13 | 99.69 | Upgrade |
Net Income | 131.59 | 158.76 | 111.26 | 92.13 | 99.69 | Upgrade |
Net Income to Common | 131.59 | 158.76 | 111.26 | 92.13 | 99.69 | Upgrade |
Net Income Growth | -17.11% | 42.69% | 20.77% | -7.58% | - | Upgrade |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | Upgrade |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | Upgrade |
Shares Change (YoY) | -0.04% | - | 0.27% | 3.93% | 1.44% | Upgrade |
EPS (Basic) | 7.15 | 8.62 | 6.04 | 5.04 | 5.68 | Upgrade |
EPS (Diluted) | 7.12 | 8.58 | 6.01 | 4.99 | 5.62 | Upgrade |
EPS Growth | -17.02% | 42.76% | 20.44% | -11.21% | - | Upgrade |
Free Cash Flow | 130.24 | 196.41 | 118.49 | 141.4 | 108.84 | Upgrade |
Free Cash Flow Per Share | 7.04 | 10.62 | 6.41 | 7.67 | 6.13 | Upgrade |
Dividend Per Share | 7.000 | 6.600 | 5.000 | 4.000 | 3.000 | Upgrade |
Dividend Growth | 6.06% | 32.00% | 25.00% | 33.33% | - | Upgrade |
Gross Margin | 45.44% | 49.02% | 43.60% | 44.25% | 40.35% | Upgrade |
Operating Margin | 22.91% | 27.66% | 22.40% | 21.49% | 16.57% | Upgrade |
Profit Margin | 18.93% | 22.39% | 18.34% | 17.17% | 19.73% | Upgrade |
Free Cash Flow Margin | 18.74% | 27.70% | 19.54% | 26.36% | 21.55% | Upgrade |
EBITDA | 185.07 | 221.25 | 171.37 | 149.31 | 118.2 | Upgrade |
EBITDA Margin | 26.63% | 31.20% | 28.26% | 27.83% | 23.40% | Upgrade |
D&A For EBITDA | 25.82 | 25.15 | 35.51 | 34.03 | 34.48 | Upgrade |
EBIT | 159.26 | 196.1 | 135.86 | 115.29 | 83.72 | Upgrade |
EBIT Margin | 22.91% | 27.66% | 22.40% | 21.49% | 16.57% | Upgrade |
Effective Tax Rate | 19.85% | 20.15% | 21.31% | 20.98% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.